<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="725d4e73-6c83-477a-adc6-0ae4a133a844"><labelDrug name="Letairis"><Normalization><mmtx cui="C1949323" preferredWord="Letairis" semType="phsu, orch"/></Normalization></labelDrug><generic name="AMBRISENTAN"/><sentence id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.1" text="Drug Label for drug brand Letairis, containing AMBRISENTAN." type="negative"><entity charOffset="47:58" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.1.e.0" text="ambrisentan" type="Biomedical_Entity"><Normalization><mmtx cui="C1176329" phraseText="AMBRISENTAN." preferredWord="ambrisentan" semType="phsu, orch"/><RxNorm RxCui="358274"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.1.e.1" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand Letairis," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="26:34" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.1.e.2" text="letairis" type="Biomedical_Entity"><Normalization><mmtx cui="C1949323" phraseText="Drug Label for drug brand Letairis," preferredWord="Letairis" semType="phsu, orch"/><RxNorm RxCui="722117"/></Normalization></entity><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.1.e.1" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.1.e.0"/><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.1.e.2" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.1.e.0"/><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.1.e.1" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.1.e.2"/></sentence><sentence id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.5" text="Pregnancy must therefore be excluded before the initiation of treatment with LETAIRIS and prevented during treatment and for one month after stopping treatment by the use of two acceptable methods of contraception unless the patient has had a tubal sterilization or chooses to use a Copper T 380A IUD or LNg 20 IUS, in which case no additional contraception is needed. " type="negative"><entity charOffset="77:85" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.5.e.0" text="letairis" type="Biomedical_Entity"><Normalization><mmtx cui="C1949323" phraseText="with LETAIRIS" preferredWord="Letairis" semType="phsu, orch"/><RxNorm RxCui="722117"/></Normalization></entity><entity charOffset="283:289" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.5.e.1" text="copper" type="Biomedical_Entity"><Normalization><mmtx cui="C0009968" phraseText="a Copper T 380A IUD" preferredWord="Copper" semType="bacs, phsu, elii"/><RxNorm RxCui="2837"/></Normalization></entity><entity charOffset="90:99" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.5.e.2" text="prevented" type="Biomedical_Entity"><Normalization><mmtx cui="C0309872" phraseText="prevented during treatment" preferredWord="PREVENT (product)" semType="phsu"/><RxNorm RxCui="1076824"/></Normalization></entity><entity charOffset="141:149" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.5.e.3" text="stopping" type="Biomedical_Entity"><Normalization><mmtx cui="C0723457" phraseText="after stopping treatment" preferredWord="Stop brand of fluoride" semType="inch, phsu"/><RxNorm RxCui="220037"/></Normalization></entity><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.5.e.0" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.5.e.1"/><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.5.e.0" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.5.e.2"/><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.5.e.0" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.5.e.3"/><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.5.e.2" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.5.e.1"/><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.5.e.3" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.5.e.1"/><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.5.e.2" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.5.e.3"/></sentence><sentence id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.13" text="&lt;item&gt;Prevent pregnancy during treatment and for one month after stopping treatment by the use of two acceptable methods of contraception unless the patient has had a tubal sterilization or chooses to use a Copper T 380A IUD or LNg 20 IUS, in which case no additional contraception is needed (5.1)." type="negative"><entity charOffset="65:73" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.13.e.0" text="stopping" type="Biomedical_Entity"><Normalization><mmtx cui="C0723457" phraseText="after stopping treatment" preferredWord="Stop brand of fluoride" semType="inch, phsu"/><RxNorm RxCui="220037"/></Normalization></entity><entity charOffset="207:213" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.13.e.1" text="copper" type="Biomedical_Entity"><Normalization><mmtx cui="C0009968" phraseText="a Copper T 380A IUD" preferredWord="Copper" semType="bacs, phsu, elii"/><RxNorm RxCui="2837"/></Normalization></entity><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.13.e.0" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.13.e.1"/></sentence><sentence id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.32" text="There are no data on the use of LETAIRIS in pregnant women." type="negative"><entity charOffset="10:17" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.32.e.0" text="no data" type="Biomedical_Entity"><Normalization><mmtx cui="C1572381" phraseText="no data on the use of LETAIRIS" preferredWord="No Data re: Ingredient" semType="phsu"/><RxNorm RxCui="53704"/></Normalization></entity><entity charOffset="32:40" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.32.e.1" text="letairis" type="Biomedical_Entity"><Normalization><mmtx cui="C1949323" phraseText="no data on the use of LETAIRIS" preferredWord="Letairis" semType="phsu, orch"/><RxNorm RxCui="722117"/></Normalization></entity><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.32.e.0" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.32.e.1"/></sentence><sentence id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.35" text="Pregnancy must be excluded before the initiation of treatment with LETAIRIS and prevented during treatment and for one month after stopping treatment see Dosage and Administration (2.2), Warnings and Precautions (5.1)." type="negative"><entity charOffset="80:89" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.35.e.0" text="prevented" type="Biomedical_Entity"><Normalization><mmtx cui="C0309872" phraseText="prevented during treatment" preferredWord="PREVENT (product)" semType="phsu"/><RxNorm RxCui="1076824"/></Normalization></entity><entity charOffset="131:139" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.35.e.1" text="stopping" type="Biomedical_Entity"><Normalization><mmtx cui="C0723457" phraseText="after stopping treatment" preferredWord="Stop brand of fluoride" semType="inch, phsu"/><RxNorm RxCui="220037"/></Normalization></entity><entity charOffset="67:75" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.35.e.2" text="letairis" type="Biomedical_Entity"><Normalization><mmtx cui="C1949323" phraseText="with LETAIRIS" preferredWord="Letairis" semType="phsu, orch"/><RxNorm RxCui="722117"/></Normalization></entity><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.35.e.0" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.35.e.1"/><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.35.e.2" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.35.e.0"/><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.35.e.2" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.35.e.1"/></sentence><sentence id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.55" text="If patients develop acute pulmonary edema during initiation of therapy with vasodilating agents such as LETAIRIS, the possibility of pulmonary veno-occlusive disease should be considered, and if confirmed LETAIRIS should be discontinued." type="negative"><entity charOffset="104:112" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.55.e.0" text="letairis" type="Biomedical_Entity"><Normalization><mmtx cui="C1949323" phraseText="such as LETAIRIS," preferredWord="Letairis" semType="phsu, orch"/><RxNorm RxCui="722117"/></Normalization></entity><entity charOffset="76:95" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.55.e.1" text="vasodilating agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0042402" phraseText="with vasodilating agents" preferredWord="Vasodilator Agents" semType="phsu"/><RxNorm RxCui="11146"/></Normalization></entity><entity charOffset="205:213" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.55.e.2" text="letairis" type="Biomedical_Entity"><Normalization><mmtx cui="C1949323" phraseText="confirmed LETAIRIS" preferredWord="Letairis" semType="phsu, orch"/><RxNorm RxCui="722117"/></Normalization></entity><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.55.e.1" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.55.e.0"/><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.55.e.1" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.55.e.2"/></sentence><sentence id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.56" text="In a 6-month study of another endothelin receptor antagonist, bosentan, 25 male patients with WHO functional class III and IV PAH and normal baseline sperm count were evaluated for effects on testicular function. " type="negative"><entity charOffset="62:70" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.56.e.0" text="bosentan" type="Biomedical_Entity"><Normalization><mmtx cui="C0252643" phraseText="bosentan," preferredWord="bosentan" semType="phsu, orch"/><RxNorm RxCui="75207"/></Normalization></entity><entity charOffset="30:60" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.56.e.1" text="endothelin receptor antagonist" type="Biomedical_Entity"><Normalization><mmtx cui="C1134681" phraseText="of another endothelin receptor antagonist," preferredWord="Endothelin receptor antagonist" semType="phsu"/><RxNorm RxCui="40080"/></Normalization></entity><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.56.e.1" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.56.e.0"/></sentence><sentence id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.61" text="Based on these findings and preclinical data see Nonclinical Toxicology (13.1) from endothelin receptor antagonists, it cannot be excluded that endothelin receptor antagonists such as LETAIRIS have an adverse effect on spermatogenesis." type="negative"><entity charOffset="144:175" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.61.e.0" text="endothelin receptor antagonists" type="Biomedical_Entity"><Normalization><mmtx cui="C1134681" phraseText="that endothelin receptor antagonists such as LETAIRIS" preferredWord="Endothelin receptor antagonist" semType="phsu"/><RxNorm RxCui="40080"/></Normalization></entity><entity charOffset="84:115" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.61.e.1" text="endothelin receptor antagonists" type="Biomedical_Entity"><Normalization><mmtx cui="C1134681" phraseText="from endothelin receptor antagonists," preferredWord="Endothelin receptor antagonist" semType="phsu"/><RxNorm RxCui="40080"/></Normalization></entity><entity charOffset="184:192" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.61.e.2" text="letairis" type="Biomedical_Entity"><Normalization><mmtx cui="C1949323" phraseText="that endothelin receptor antagonists such as LETAIRIS" preferredWord="Letairis" semType="phsu, orch"/><RxNorm RxCui="722117"/></Normalization></entity><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.61.e.0" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.61.e.2"/><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.61.e.1" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.61.e.2"/></sentence><sentence id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.62" text="Decreases in hemoglobin concentration and hematocrit have followed administration of other endothelin receptor antagonists and were observed in clinical studies with LETAIRIS. " type="negative"><entity charOffset="166:174" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.62.e.0" text="letairis" type="Biomedical_Entity"><Normalization><mmtx cui="C1949323" phraseText="with LETAIRIS." preferredWord="Letairis" semType="phsu, orch"/><RxNorm RxCui="722117"/></Normalization></entity><entity charOffset="91:122" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.62.e.1" text="endothelin receptor antagonists" type="Biomedical_Entity"><Normalization><mmtx cui="C3537018" phraseText="followed administration of other endothelin receptor antagonists" preferredWord="Endothelin Receptor Antagonist [EPC]" semType="phsu"/><RxNorm RxCui="40080"/></Normalization></entity><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.62.e.1" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.62.e.0"/></sentence><sentence biomedicalEntities="4" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.73" lineNumber="83" text="Multiple dose co-administration of ambrisentan and cyclosporine resulted in an approximately 2-fold increase in ambrisentan exposure in healthy volunteers, therefore, limit the dose of ambrisentan to 5 mg once daily when co-administered with cyclosporine see Clinical Pharmacology (12.3)." type="regular"><entity charOffset="100:111|124:132" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.73.e.0" text="increase in exposure" type="Increase_Interaction"/><entity charOffset="51:63" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.73.e.2" text="cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="cyclosporine" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="112:123" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.73.e.3" text="ambrisentan" type="Drug"><Normalization><mmtx cui="C1176329" phraseText="in ambrisentan exposure" preferredWord="ambrisentan" semType="phsu, orch"/><RxNorm RxCui="358274"/></Normalization></entity><entity charOffset="167:181" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.73.e.4" text="limit the dose" type="Caution_Interaction"/><entity charOffset="185:196" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.73.e.6" text="ambrisentan" type="Drug"><Normalization><mmtx cui="C1176329" phraseText="the dose of ambrisentan" preferredWord="ambrisentan" semType="phsu, orch"/><RxNorm RxCui="358274"/></Normalization></entity><entity charOffset="242:254" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.73.e.7" text="cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="co-administered with cyclosporine" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><drugInteraction id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.73.ddi.1"><interaction trigger="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.73.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.73.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.73.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.73.ddi.2"><interaction trigger="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.73.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.73.e.7"/></relation><relation type="hasObject"><entity id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.73.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.73.e.2" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.73.e.3" trigger="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.73.e.0" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.73.e.6" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.73.e.7" trigger="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.73.e.4" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.74" lineNumber="84" text="Multiple dose co-administration of ambrisentan and cyclosporine resulted in an about 2-fold increase in ambrisentan exposure in healthy volunteers. " type="regular"><entity charOffset="92:103|116:124" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.74.e.0" text="increase in exposure" type="Increase_Interaction"/><entity charOffset="104:115" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.74.e.2" text="ambrisentan" type="Drug"><Normalization><mmtx cui="C1176329" phraseText="in ambrisentan exposure" preferredWord="ambrisentan" semType="phsu, orch"/><RxNorm RxCui="358274"/></Normalization></entity><entity charOffset="51:63" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.74.e.3" text="cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="cyclosporine" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><drugInteraction id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.74.ddi.1"><interaction trigger="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.74.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.74.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.74.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.74.e.3" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.74.e.2" trigger="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.74.e.0" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.75" lineNumber="84" text="When co-administered with cyclosporine, limit the dose to 5 mg once daily (7)." type="irregular"><entity charOffset="26:38" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.75.e.0" text="cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="co-administered with cyclosporine," preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="40:54" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.75.e.1" text="limit the dose" type="Caution_Interaction"/><drugInteraction id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.75.ddi.1"><interaction trigger="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.75.e.1"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.74" text="Multiple dose co-administration of ambrisentan and cyclosporine resulted in an about 2-fold increase in ambrisentan exposure in healthy volunteers. "><entity id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.74.e.2"/></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.75.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.75.e.0"/></sentence><sentence id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.77" text="&lt;main&gt;LETAIRIS is the brand name for ambrisentan, an endothelin receptor antagonist that is selective for the endothelin type-A (ETA) receptor. " type="negative"><entity charOffset="6:14" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.77.e.0" text="letairis" type="Biomedical_Entity"><Normalization><mmtx cui="C1949323" phraseText="&gt;LETAIRIS" preferredWord="Letairis" semType="phsu, orch"/><RxNorm RxCui="722117"/></Normalization></entity><entity charOffset="37:48" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.77.e.1" text="ambrisentan" type="Biomedical_Entity"><Normalization><mmtx cui="C1176329" phraseText="the brand name for ambrisentan," preferredWord="ambrisentan" semType="phsu, orch"/><RxNorm RxCui="358274"/></Normalization></entity><entity charOffset="53:83" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.77.e.2" text="endothelin receptor antagonist" type="Biomedical_Entity"><Normalization><mmtx cui="C1134681" phraseText="an endothelin receptor antagonist" preferredWord="Endothelin receptor antagonist" semType="phsu"/><RxNorm RxCui="40080"/></Normalization></entity><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.77.e.0" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.77.e.1"/><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.77.e.0" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.77.e.2"/><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.77.e.1" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.77.e.2"/></sentence><sentence id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.84" text="Ambrisentan is practically insoluble in water and in aqueous solutions at low pH. " type="negative"><entity charOffset="0:11" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.84.e.0" text="ambrisentan" type="Biomedical_Entity"><Normalization><mmtx cui="C1176329" phraseText="Ambrisentan" preferredWord="ambrisentan" semType="phsu, orch"/><RxNorm RxCui="358274"/></Normalization></entity><entity charOffset="53:70" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.84.e.1" text="aqueous solutions" type="Biomedical_Entity"><Normalization><mmtx cui="C3255993" phraseText="and in aqueous solutions" preferredWord="aqueous solution" semType="phsu"/><RxNorm RxCui="1239375"/></Normalization></entity><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.84.e.0" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.84.e.1"/></sentence><sentence id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.88" text="The tablets include the following inactive ingredients: croscarmellose sodium, lactose monohydrate, magnesium stearate and microcrystalline cellulose. " type="negative"><entity charOffset="100:118" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.88.e.0" text="magnesium stearate" type="Biomedical_Entity"><Normalization><mmtx cui="C0126791" phraseText="magnesium stearate" preferredWord="Magnesium stearate" semType="phsu, lipd"/><RxNorm RxCui="6574"/></Normalization></entity><entity charOffset="79:98" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.88.e.1" text="lactose monohydrate" type="Biomedical_Entity"><Normalization><mmtx cui="C1658042" phraseText="lactose monohydrate," preferredWord="Lactose Monohydrate" semType="phsu, orch"/><RxNorm RxCui="6211"/></Normalization></entity><entity charOffset="123:149" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.88.e.2" text="microcrystalline cellulose" type="Biomedical_Entity"><Normalization><mmtx cui="C3255827" phraseText="microcrystalline cellulose." preferredWord="micro-crystalline cellulose" semType="phsu"/><RxNorm RxCui="1239123"/></Normalization></entity><entity charOffset="56:77" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.88.e.3" text="croscarmellose sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0010353" phraseText="croscarmellose sodium," preferredWord="Croscarmellose Sodium" semType="phsu, carb"/><RxNorm RxCui="1310574"/></Normalization></entity><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.88.e.1" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.88.e.0"/><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.88.e.0" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.88.e.2"/><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.88.e.3" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.88.e.0"/><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.88.e.1" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.88.e.2"/><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.88.e.3" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.88.e.1"/><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.88.e.3" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.88.e.2"/></sentence><sentence id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.89" text="The tablets are film-coated with a coating material containing FD - C Red #40 aluminum lake, lecithin, polyethylene glycol, polyvinyl alcohol, talc, and titanium dioxide. " type="negative"><entity charOffset="153:169" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.89.e.0" text="titanium dioxide" type="Biomedical_Entity"><Normalization><mmtx cui="C0076733" phraseText="titanium dioxide." preferredWord="titanium dioxide" semType="inch, phsu"/><RxNorm RxCui="1305547"/></Normalization></entity><entity charOffset="143:147" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.89.e.1" text="talc" type="Biomedical_Entity"><Normalization><mmtx cui="C0039267" phraseText="talc," preferredWord="Talc" semType="inch, phsu, bodm"/><RxNorm RxCui="10323"/></Normalization></entity><entity charOffset="103:122" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.89.e.2" text="polyethylene glycol" type="Biomedical_Entity"><Normalization><mmtx cui="C0032483" phraseText="polyethylene glycol," preferredWord="Polyethylene Glycols" semType="phsu, bodm, orch"/><RxNorm RxCui="54961"/></Normalization></entity><entity charOffset="93:101" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.89.e.3" text="lecithin" type="Biomedical_Entity"><Normalization><mmtx cui="C0885520" phraseText="lecithin," preferredWord="Lecithinum, lecithin, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="8214"/></Normalization></entity><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.89.e.1" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.89.e.0"/><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.89.e.2" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.89.e.0"/><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.89.e.3" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.89.e.0"/><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.89.e.2" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.89.e.1"/><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.89.e.3" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.89.e.1"/><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.89.e.3" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.89.e.2"/></sentence><sentence id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.90" text="Each square, pale pink LETAIRIS tablet contains 5 mg of ambrisentan. " type="negative"><entity charOffset="23:31" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.90.e.0" text="letairis" type="Biomedical_Entity"><Normalization><mmtx cui="C1949323" phraseText="pale pink LETAIRIS tablet" preferredWord="Letairis" semType="phsu, orch"/><RxNorm RxCui="722117"/></Normalization></entity><entity charOffset="48:67" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.90.e.1" text="5 mg ambrisentan" type="Biomedical_Entity"><Normalization><mmtx cui="C1949327" phraseText="5 mg of ambrisentan." preferredWord="ambrisentan 5 MG" semType="clnd"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.90.e.0" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.90.e.1"/></sentence><sentence id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.91" text="Each oval, deep pink LETAIRIS tablet contains 10 mg of ambrisentan. " type="negative"><entity charOffset="21:29" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.91.e.0" text="letairis" type="Biomedical_Entity"><Normalization><mmtx cui="C1949323" phraseText="deep pink LETAIRIS tablet" preferredWord="Letairis" semType="phsu, orch"/><RxNorm RxCui="722117"/></Normalization></entity><entity charOffset="46:66" id="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.91.e.1" text="10 mg ambrisentan" type="Biomedical_Entity"><Normalization><mmtx cui="C1949320" phraseText="10 mg of ambrisentan." preferredWord="ambrisentan 10 MG" semType="clnd"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.91.e.0" e2="Dailymed.725d4e73-6c83-477a-adc6-0ae4a133a844.s.91.e.1"/></sentence><positiveExamples number="4"/><negativeExamples number="38"/></document>